166 related articles for article (PubMed ID: 35023789)
1. MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN.
Teerapakpinyo C; Areeruk W; Tantbirojn P; Phupong V; Shuangshoti S; Lertkhachonsuk R
Technol Cancer Res Treat; 2022; 21():15330338211067309. PubMed ID: 35023789
[No Abstract] [Full Text] [Related]
2. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
3. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia.
Rakprasit C; Ruengkhachorn I; Therasakvichya S; Inthasorn P; Achariyapota V; Kuljarasnont S; Khemworapong K; Jareemit N
Arch Gynecol Obstet; 2023 Apr; 307(4):1145-1154. PubMed ID: 36116082
[TBL] [Abstract][Full Text] [Related]
6. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of the proliferative marker Ki67 in hydatidiform moles and its diagnostic value in the progression to gestational trophoblastic neoplasia.
Hasanzadeh M; Sharifi N; Esmaieli H; Daloee MS; Tabari A
J Obstet Gynaecol Res; 2013 Feb; 39(2):572-7. PubMed ID: 22925155
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNA signature in the progression of gestational trophoblastic disease.
Zhao JR; Cheng WW; Wang YX; Cai M; Wu WB; Zhang HJ
Cell Death Dis; 2018 Jan; 9(2):94. PubMed ID: 29367697
[TBL] [Abstract][Full Text] [Related]
9. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
Sato A; Usui H; Shozu M
Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
[TBL] [Abstract][Full Text] [Related]
10. A Novel Prediction Model for Postmolar Gestational Trophoblastic Neoplasia and Comparison With Existing Models.
Zhao P; Wang S; Zhang X; Lu W
Int J Gynecol Cancer; 2017 Jun; 27(5):1028-1034. PubMed ID: 28498254
[TBL] [Abstract][Full Text] [Related]
11. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
12. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
13. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling in complete and partial hydatidiform moles.
Chia WK; Yeoh HXY; Mustangin M; Khong TY; Wong YP; Tan GC
Malays J Pathol; 2023 Dec; 45(3):353-362. PubMed ID: 38155377
[TBL] [Abstract][Full Text] [Related]
15. LINE-1 Methylation Patterns as a Predictor of Postmolar Gestational Trophoblastic Neoplasia.
Lertkhachonsuk R; Paiwattananupant K; Tantbirojn P; Rattanatanyong P; Mutirangura A
Biomed Res Int; 2015; 2015():421747. PubMed ID: 26448937
[TBL] [Abstract][Full Text] [Related]
16. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
17. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
18. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms.
Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W
Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420
[TBL] [Abstract][Full Text] [Related]
20. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]